Endogenous production of β-chemokines by CD4+, but not CD8+ T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 876-881

  Saha, Kunal ^a   Bentsman, Galina ^a   Chess, Leonard ^a   Volsky, David J ^a,b  

^a Columbia University ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEINASE INHIBITOR; RANTES; RECOMBINANT INTERLEUKIN 2; RO 31 9859; SAQUINAVIR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; LYMPHOCYTE CLONE; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL; VIRUS REPLICATION;

EID: 0031964686     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.876-881.1998     Document Type: Article

References (33)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, and MIP-1β receptor as a fusin cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
2. Broker, B. M., A. Y. Tsygankov, I. Muller-Fleckenstein, A. H. Guse, N. A. Chitaev, B. Biesinger, B. Fleckenstein, and F. Emmrich. 1993. Immortalization of human T cell clones by herpesvirus saimiri: signal transduction analysis reveals functional CD3, CD4, and IL-2 receptors. J. Immunol. 151:1184-1192.
3. + T cells, p. 159. 9th annual meeting of the National Cooperative Vaccine Development and AIDS.
4. Chowdhury, I. H., W. Chao, M. J. Potash, P. Sova, H. E. Gendelman, and D. J. Volsky. 1996. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J. Virol. 70:5336-5345.
5. Clerici, M., C. Balotta, D. Trabattoni, L. Papagno, S. Ruzzante, S. Rusconi, M. L. Fusi, M. C. Colombo, and M. Galli. 1996. Chemokine production in HIV-1-seropositive long-term asymptomatic individuals. AIDS 10:1432-1433.
6. Clerici, M., and G. M. Shearer. 1995. The TH1-TH2 hypothesis of HIV-1 infection: new insights. Immunol. Today 15:575-581.
7. + T cells. Science 270:1811-1815.
8. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. D. Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
9. + cells is mediated by chemokine receptor CC-CKR5. Nature 381:667-673.
10. Haynes, B. F., G. Pantaleo, and A. S. Fauci. 1996. Toward an understanding of the correlates of protective immunity to HIV-1 infection. Science 271:324-328.
11. + T cells of HIV-1-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA 93:14076-14081.
12. + T cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage-inflammatory protein (MIP)-1α and MIP-1β. AIDS 11:575-580.
13. Levy, J. A. 1993. HIV-1 pathogenesis and long-term survival. AIDS 7:1401-1410.
14. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stullmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
15. Mackewicz, C. E., E. Barker, and J. A. Levy. 1996. Role of β-chemokines in suppressing HIV-1 replication. Science 274:1393-1394.
16. Meinl, E., R. Hohlfeld, H. Wekerle, and B. Fleckenstein. 1995. Immortalization of human T cells by herpesvirus saimiri. Immunol. Today 16:55-58.
17. Mittrucker, H. W., I. Muller-Fleckenstein, B. Fleckenstein, and B. Fleischer. 1993. Herpesvirus saimiri-transformed human T lymphocytes: normal functional phenotype and preserved T cell receptor signaling. Int. Immunol. 5:985-990.
18. + T cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophage. Proc. Natl. Acad. Sci. USA 93:15341-15345.
19. Nick, S., H. Fickenscher, B. Biesinger, G. Born, G. Jahn, and B. Fleckenstein. 1993. Herpesvirus saimiri transformed human T cell lines: a permissive system for human immunodeficiency viruses. Virology 194:875-877.
20. + T cell clones. AIDS 10:1317-1321.
21. Pantaleo, G., S. Menzo, and M. Vaccarezza. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
22. Roberts, N., et al. 1990. Rational design of peptide-based HIV-1 proteinase inhibitors. Science 248:358-362.
23. Saha, K., M. Caruso, and D. J. Volsky. 1997. Human immunodeficiency virus type 1 (HIV-1) infection of herpesvirus saimiri-immortalized human CD4-positive T lymphoblastoid cells: evidence of enhanced HIV-1 replication and cytopathic effects caused by endogenous IFN-γ. Virology 231:1-9.
24. + T cell clones from PBLs of HIV-1 infected subjects using herpesvirus saimiri. Nat. Med. 2:1272-1275.
25. + T cells can provide polyclonal B cell help via the CD40 ligand as well as the TNF-α pathway and through release of lymphokines. J. Immunol. 157:3876-3885.
26. + T cell clones from peripheral blood lymphocytes of AIDS patients. J. Immunol. Methods 206:21-23.
27. Saha, K., and D. J. Volsky. Unpublished data.
28. + T cells in order to cause paralysis and immunodeficiency. J. Virol. 66:2639-2646.
29. Scala, E., G. D'Offizi, R. Rooso, O. Turriziani, R. Ferrara, A. M. Mazzone, G. Antonelli, F. Aiuti, and R. Paganelli. 1997. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV-1 infection. J. Immunol. 158:4485-4492.
30. Schmidtmayerova, H., B. Sherry, and M. Bukrinsky. 1996. Chemokines and HIV-1 replication. Nature 382:767.
31. Volsky, D. J., M. Simm, M. Shahabuddin, G. Li, W. Chao, and M. J. Potash. 1996. Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. J. Virol. 70:3823-3833.
32. Weber, F., E. Meinl, K. Drexler, A. Czlonkowska, S. Huber, H. Fickenscher, I. Muller-Fleckenstein, H. Wekerle, and R. Hohlfeld. 1993. Transformation of human T cell clones by herpesvirus saimiri: intact antigen recognition by autonomously growing myelin basic protein-specific T cells. Proc. Natl. Acad. Sci. USA 90:11049-11053.
33. Zanussi, S., M. D. Andrea, C. Simonelli, V. Tirelli, and P. DePaoli. 1996. Serum levels of RANTES and MIP-1α in HIV-1-positive long-term survivors and progressor patients. AIDS 10:1431-1432.